• Belgian research team uses AI to explain cell diversity in the fly brain

    Thursday January 6th 2022

  • VIB research at the basis of experimental gene therapy against dementia

    Wednesday December 22nd 2021

  • reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase

    Thursday October 21st 2021

  • Rejuvenate Biomed raises a EUR 15.7 million Series B to accelerate clinical development of its sarcopenia treatment for healthy aging

    Tuesday October 12th 2021

  • Bone Therapeutics appoints Scientific Advisory Board for iMSC cell and gene therapy platform development

    Tuesday October 12th 2021

  • KU Leuven develops very potent antiviral against dengue

    Thursday October 7th 2021

  • OXURION announces positive results from Part A of Phase 2 Study evaluating THR-149 for treatment of Diabetic Macular Edema (DME)

    Thursday September 30th 2021

  • Bone Therapeutics signs research partnership with Implant Therapeutics to access induced Pluripotent Stem Cells (iPSC)

    Wednesday September 29th 2021

  • Your news here?

  • Donesta® Phase III: recruitment completion of American study and additional recruitment in the European study

    Wednesday September 22nd 2021

  • Mithra announces an update on PeriNesta®

    Wednesday September 22nd 2021

  • Galapagos announces positive CHMP opinion for Jyseleca® (filgotinib) for the treatment of adults with moderately to severely active ulcerative colitis

    Friday September 17th 2021

Strategic Partners